Pharma Stock under ₹50 jumps after receiving order from Kuwait based company

The shares of a Microcap Pharmaceutical company that focuses on manufacturing ayurvedic and herbal products with a well-built presence in Human Pharma and the Veterinary space are in focus after securing a noteworthy international order. 

Price Action 

The shares of Shelter Pharma Ltd, with a total market of 47.61 Crore on Friday, reached an Intraday high at Rs 41.19 per share which was 2.9 percent higher than the previous closing price of Rs 40.04. 

About the Order

As per a press release dated March 21, 2025, Shelter Pharma Ltd announced that it secured a noteworthy order from Berlin International Co., a Kuwait-based company, for the supply of 6000 Beta Glucan Forte Syrup 100ml, for a consideration of $9,900. 

Previous Orders

The company received significant orders in February, it bagged an order from Taha Drugs & Chemicals Co. Ltd For 50,000 Boxes of Joemega Capsual and 75,000 Boxes of Allvitamins Tablet which is worth $1,01,250, and an order from BioPharma SA Medical Store For coughNal 100ml worth $8750. 

Also read: 5 Defence stocks to benefit as DAC approves ₹54,000 Cr defence acquisitions to strengthen India’s military

Financials 

The company reported a 25 percent year-over-year increase in Revenue from Operations, from Rs 19.31 Crore in H1FY24 to Rs 24.06 Crore in H1FY25. Over the same period, their net profits increased by 14 percent year-over-year, from Rs 3.1 Crore to Rs 3.54 Crore. 

Key Ratios 

The company boasts a lower D/E ratio of 0.03, and its P/E ratio is 7.36X, which is less than the industry average of 30.53X. It has an ROE of 16.92 percent with an ROCE of 22.17 percent. The company has a strong 3-year CAGR for Revenue at 21.19 percent, Net Profit at 431.9 percent, and Operating Profit at 263.3 percent.

About Shelter Pharma Ltd

Shelter Pharma Ltd is a leading pharmaceutical and nutraceutical company. It is primarily engaged in the manufacturing of ayurvedic and herbal products with a well-built presence in Human Pharma as well as Veterinary space. The company specializes in producing generic medicines, formulations, and active pharmaceutical ingredients (APIs). 

Written By Adhvaitha Nayani

Disclaimer

The views and investment tips expressed by investment experts/broking houses/rating agencies on tradebrains.in are their own, and not that of the website or its management. Investing in equities poses a risk of financial losses. Investors must therefore exercise due caution while investing or trading in stocks. Dailyraven Technologies or the author are not liable for any losses caused as a result of the decision based on this article. Please consult your investment advisor before investing.

The post Pharma Stock under ₹50 jumps after receiving order from Kuwait based company appeared first on Trade Brains.